CANADA LIFE ASSURANCE Co - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2018. The put-call ratio across all filers is 3.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2023$38
+100.0%
23,552
+683.5%
0.00%
Q4 2022$19
-99.9%
3,006
+81.1%
0.00%
Q3 2021$20,000
-42.9%
1,6600.0%0.00%
Q2 2021$35,000
-23.9%
1,6600.0%0.00%
Q1 2021$46,000
+7.0%
1,6600.0%0.00%
Q4 2020$43,000
-30.6%
1,6600.0%0.00%
Q3 2020$62,000
-27.1%
1,6600.0%0.00%
Q2 2020$85,000
+60.4%
1,6600.0%0.00%
Q1 2020$53,000
-45.9%
1,6600.0%0.00%
Q4 2019$98,000
+60.7%
1,6600.0%0.00%
Q3 2019$61,000
-57.9%
1,660
-46.9%
0.00%
Q2 2019$145,000
+16.0%
3,1280.0%0.00%
Q1 2019$125,000
-10.1%
3,1280.0%0.00%
Q4 2018$139,0000.0%3,1280.0%0.00%
Q3 2018$139,000
+13.0%
3,1280.0%0.00%
Q2 2018$123,000
-45.8%
3,1280.0%0.00%
-100.0%
Q1 2018$227,000
+10.2%
3,1280.0%0.00%
Q4 2017$206,000
+216.9%
3,128
+140.6%
0.00%
Q3 2017$65,000
+8.3%
1,3000.0%0.00%
Q2 2017$60,000
+30.4%
1,3000.0%0.00%
Q1 2017$46,000
+187.5%
1,3000.0%0.00%
Q4 2016$16,000
-55.6%
1,300
-50.0%
0.00%
Q3 2016$36,000
+176.9%
2,600
+100.0%
0.00%
Q2 2016$13,000
-40.9%
1,3000.0%0.00%
Q1 2016$22,000
-24.1%
1,3000.0%0.00%
Q4 2015$29,000
-6.5%
1,3000.0%0.00%
Q3 2015$31,000
-70.8%
1,3000.0%0.00%
Q2 2015$106,000
-11.7%
1,3000.0%0.00%
Q1 2015$120,0001,3000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2018
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$27,840,84218.82%
Ikarian Capital, LLC 1,891,147$11,781,8462.84%
Altium Capital Management LP 620,000$3,862,6001.96%
Ikarian Capital, LLC 1,296,900$8,079,6871.95%
Parkman Healthcare Partners LLC 822,784$5,125,9441.36%
Deep Track Capital, LP 4,000,000$24,920,0001.05%
Monaco Asset Management SAM 470,100$2,928,7230.88%
BRAIDWELL LP 3,393,405$21,140,9130.71%
Telemetry Investments, L.L.C. 71,000$4420.70%
Rhenman & Partners Asset Management AB 900,000$5,607,0000.58%
View complete list of ESPERION THERAPEUTICS INC NE shareholders